BOC Sciences provides a wide range of research chemicals and biochemicals including inhibitors, building blocks, GMP Products, impurities and metabolites, APIs for Veterinary, Natural Compounds, ADCs, Stem Cell Molecule and chiral compounds.
| Product | Description | |
|---|---|---|
| Gypenoside XLIX | Gypenoside XLIX inhibits LPS-induced TF overexpression and enhancement of its activity in human THP-1 monocytic cells via PPAR-alpha-dependent pathways. Synonyms: Gypenoside XLIX; (3beta)-3-[(O-6-Deoxy-alpha-L-mannopyranosyl-(1-2)-O-[beta-D-xylopyranosyl-(1-3)]-alpha-L-arabinopyranosyl)oxy]-21-(beta-D-glucopyranosyloxy)-20-hydroxy-dammar-24-en-19-al. Grades: >98%. CAS No. 94987-08-3. Molecular formula: C52H86O21. Mole weight: 1047.23. |  |
| Haloperidol-1-hydroxy-2-b-D-glucuronide | Haloperidol-1-hydroxy-2-b-D-glucuronide is a paramount metabolite originating from the prominent antipsychotic compound Haloperidol, unveiling its significance in the realm of Haloperidol research efficacy assessment through its prevalence in excreted urine samples. CAS No. 100442-86-2. Molecular formula: C27H33ClFNO9. Mole weight: 570.00. | |
| HaloTag O2 Tobramycin | HaloTag O2 Tobramycin is a derivative compound of Tobramycin, a single factor antibiotic comprising about 10% of nebramycin, the aminoglycosidic antibiotic complex produced by Streptomyces tenebrarius. An antibacterial. Synonyms: N- ( ( (2R, 3S, 5R, 6R) -5-amino-6- ( ( (2S, 3S, 4R, 6S) -4, 6-diamino-3- ( ( (2S, 3R, 4S, 5S, 6R) -4-amino-3, 5-dihydroxy-6- (hydromethyl) tetrahydro-2H-pyran-2-yl) oxy) -2-hydroxycyclohexyl) oxy-3-hydroxytetrahydro-2H-pyran-2-yl) methyl) -4- ( (2- (2 ( (6-chlorohexyl) oxyl) ethoxy) ethyl) amino) butanamide. Grades: 95%. Molecular formula: C32H61ClN6O13. Mole weight: 773.31. | |
| Hederasaponin B | Hederasaponin B inhibites the viral VP2 protein expression, suggesting the inhibition of viral capsid protein synthesis. Uses: Antiviral. Synonyms: Hederasaponin B; 3β-(2-O-α-L-Rhamnopyranosyl-α-L-arabinopyranosyloxy)oleana-12-ene-28-oic acid 6-O-(4-O-α-L-rhamnopyranosyl-β-D-glucopyranosyl)-β-D-glucopyranosyl ester; 3β-[(2-O-α-L-Rhamnopyranosyl-α-L-arabinopyranosyl)oxy]olean-12-en-28-oic acid 6-O-(4-O-α-L-rhamnopyranosyl-β-D-glucopyranosyl)-β-D-glucopyranosyl ester; 3β-[2-O-(α-L-Rhamnopyranosyl)-α-L-arabinopyranosyloxy]oleana-12-ene-28-oic acid 6-O-[4-O-(α-L-rhamnopyranosyl)-β-D-glucopyranosyl]-β-D-glucopyranosyl ester; Saponin PJ3; HEDERASAPONIN B (RG); (3beta)-3-[[2-O-(6-Deoxy-alpha-L-mannopyranosyl)-alpha-L-arabinopyranosyl]oxy]-Olean-12-en-28-oic acid O-6-deoxy-beta-L-mannopyranosyl-(1-4)-O-beta-D-glucopyranosyl-(1-6)-beta-D-glucopyranosyl ester; Eleutheroside M. Grades: >98%. CAS No. 36284-77-2. Molecular formula: C59H96O25. Mole weight: 1205.4. | |
| Heparan sulphate sodium salt | | |
| Heparinase I | This enzyme selectively cleaves highly sulfated polysaccharide chains containing 1-4 linkages between N-sulfated glucaoamine and 2-O-sulfated iduronic acid. It cleaves heparin sulfate but only to a limited extent in the sulfated zone. It also cleaves the antithrombin III pentasaccharide unit in the heparin molecule. Optimum pH 7.0-7.6. Stabilised with 0.2-0.4% BSA, 0.22 μm sterile filtered and dispensed into sterile tubes/vials. Synonyms: Native Flavobacterium Heparinum Heparinase I; EC 4.2.2.7; Heparinase I; Heparin Eliminase; Heparinase; Heparin Lyase; Heparinase I From Bacteroides Eggerthii, Recombinant. Grades: 95%. CAS No. 9025-39-2. Mole weight: 42.8 kDa. | |
| Heparinase II from Flavobacterium heparinum | This enzyme cleaves most links in heparin and heparin sulfate. It is relatively non-specific for 1-4 links in sulfated polysaccharide chains between hexosamines and glucuronic acid plus iduronic acids, but does not fully depolymerise either. Optimum pH 7.0-7.6. Stabilised with 0.2-0.4% BSA, 0.22 μm sterile filtered and dispensed into sterile tubes/vials. Synonyms: Heparinase II; Heparin lyase II; EC 4.2.2.8. CAS No. 149371-12-0. Mole weight: 84.1 kDa. | |
| Heparinase III | The enzyme cleaves 1-4 linkages between N-acetylated or N-sulphated glucosamine and glucuronic acid residues. It is only active towards heparan sulfate in the low sulphated zone and does not cleave heparin or low molecular weight heparins. Highly sulfated zones are resistant to it and activity towards iduronic acid is very low. Stabilised with 0.2-0.4% BSA, 0.22 μm sterile filtered and dispensed into sterile tubes/vials. Synonyms: Heparinase III from Flavobacterium heparinum; Heparin Lyase III; Heparitinase I; Heparan monosulfate lyase; Heparin sulfate eliminase; Heparin-sulfate lyase. CAS No. 37290-86-1. Mole weight: 70.8 kDa. | |
| Heparin derived disaccharide sodium salt | Heparin derived disaccharide sodium salt is a biomedical product used in the research of blood clotting disorders. This sodium salt compound is derived from heparin, a drug commonly used to prevent and study deep vein thrombosand pulmonary embolism. Synonyms: 2-Deoxy-2-sulfoamino-6-O-sulfo-4-O-(2-O-sulfo-a-L-idopyranuronosyl)-a-D-glucopyranose; 4-O-(a-L-Idopyranosyluronic acid 2-sulfate)-D-glucosamine 2,6-disulfate. CAS No. 98797-50-3. Molecular formula: C12H15NO19S3 Na4. Mole weight: 665.4. | |
| Heparin derived dp10 saccharide ammonium salt | Heparin derived dp10 saccharide ammonium salt is an esteemed compound, aiding in the research of thrombosand cardiovascular ailments. Synonyms: Decasaccharide (dp10). Mole weight: ~3000 (Average). | |
| Heparin derived dp12 Saccharide ammonium salt | Heparin derived dp12 Saccharide ammonium salt is an innovative biomedical solution originating from heparin, showcasing its exceptional efficacy in studying thrombosand embolism. Its profound anticoagulant characteristics pave the way for its utilization in studying the intricate realm of cardiovascular diseases and hemodialysis. Synonyms: Dodecasaccharide (dp12). Mole weight: ~3550 (Average). | |
| Heparin derived dp14 saccharide ammonium salt | Heparin derived dp14 saccharide ammonium salt, a derivative of heparin, is renowned as an esteemed anticoagulant compound. It finds vital applicability in the research of antithrombotic therapeutic approaches. Synonyms: Tetradecasaccharide (dp14). Mole weight: ~4100 (Average). | |
| Heparin derived dp16 saccharide ammonium salt | Heparin derived dp16 saccharide ammonium salt is a pharmaceutical compound, finding widespread application in studying conditions like deep vein thrombosand pulmonary embolism. Synonyms: Hexadecasaccharide (dp16). Mole weight: ~4650 (Average). | |
| Heparin derived dp18 saccharide ammonium salt | Heparin derived dp18 saccharide ammonium salt is a biomedical product used in the research of blood clotting disorders. This compound, synthesized from heparin, exhibiting anticoagulant properties. Mole weight: ~ 5200 (average). | |
| Heparin derived dp20 saccharide ammonium salt | Heparin derived dp20 saccharide ammonium salt is a sophisticated biomedical compound employed for the research of hemostatic dysfunctions and cardiovascular pathologies. Unveiling from Heparin origin, this compound exhibits anticoagulative attributes. Mole weight: ~5750 (Average). | |
| Heparin derived dp22 saccharide ammonium salt | Heparin derived dp22 saccharide ammonium salt is an intriguing derivative arising from heparin is a formidable anticoagulant. Imbued with an intricate dp22 saccharide configuration, this structure augments its bioactive potential. The ammonium salt manifestation of this compound begets bolstered solubility and bioavailability. Mole weight: ~6300 (Average). | |
| Heparin derived dp24 saccharide ammonium salt | Heparin-derived dp24 saccharide ammonium salt is a biomedically utilized product, serving to study blood clotting disorders. It originates from heparin and comprises dp24 is a saccharide ammonium salt. Mole weight: Average 6850. | |
| Heparin derived dp26 saccharide | Heparin derived dp26 saccharide is a remarkable biomedical breakthrough, standing as an invaluable resource in the research of myriad afflictions revolving around coagulation. Infused with stellar anticoagulant attributes, this saccharide is extracted from heparin. Its mechanism entails an adroit suppression of clotting factors. Molecular formula: C156H207N13O247S39Na52. Mole weight: 8662.29. | |
| Heparin derived dp26 saccharide ammonium salt | Heparin derived dp26 saccharide ammonium salt is a biomedical product used in the treatment of blood clotting disorders. It is derived from heparin, a naturally occurring anticoagulant, and exhibits potent antithrombotic properties. This product helps prevent the formation of blood clots and is commonly used in the management of deep vein thrombosis, pulmonary embolism, and other related conditions. Molecular formula: C156H207N13O247S39Na52. Mole weight: 8662.29. | |
| Heparin derived dp4 saccharide ammonium salt | Heparin derived dp4 saccharide ammonium salt, a biomedical compound derived from heparin, showcases profound therapeutic potential in treating blood clotting disorders and cardiovascular ailments. With its distinctive attributes as a dp4 saccharide ammonium salt, it exemplifies great efficacy in averting thrombosis and mitigating associated complexities. Synonyms: Tetrasaccharide (dp4). CAS No. 61844-85-7. Molecular formula: C24H38N2O35S5. Mole weight: 1074.9. | |
| Heparin derived dp6 saccharide ammonium salt | Heparin derived dp6 saccharide ammonium salt is a biomedical product derived from heparin that effectively studys blood clotting disorders. This saccharide ammonium salt exhibits potent anticoagulant properties. Synonyms: Heparin hexasaccharide. Mole weight: ~1800 (Average). | |
| Heparin derived dp8 saccharide ammonium salt | Heparin derived dp8 saccharide ammonium salt is a biomedical product used in the research of thrombosand coagulation disorders. This drug, derived from heparin, exhibiting anticoagulant properties by inhibiting certain clotting factors in the blood. Synonyms: Octasaccharide (dp8). Mole weight: ~2400 (Average). | |
| Heparin disaccharide I-A trisodium salt | It is a minor component produced from heparin by heparinase II. Synonyms: alpha-DeltaUA-2S-[1->4]-GlcNAc-6S; α-δUA-2S-[1->4]-GlcNAc-6S; D-Glucopyranose, 2-(acetylamino)-2-deoxy-4-O-(4-deoxy-2-O-sulfo-α-L-threo-hex-4-enopyranuronosyl)-, 6-(hydrogen sulfate), sodium salt (1:3); Trisodium 2-acetamido-2-deoxy-4-O-(4-deoxy-2-O-sulfonato-α-L-threo-hex-4-enopyranuronosyl)-6-O-sulfonato-D-glucopyranose. Grades: ≥95%. CAS No. 136098-00-5. Molecular formula: C14H18NNa3O17S2. Mole weight: 605.39. | |
| Heparin disaccharide I-H trisodium salt | It is the major component from the action of heparinase II on de-N-sulfated heparin. Synonyms: Heparin unsaturated disaccharide I-H trisodium salt; alpha-DeltaUA-2S-[1->4]-GlcN-6S; Trisodium 2-amino-2-deoxy-4-O-(4-deoxy-2-O-sulfonato-alpha-L-threo-hex-4-enopyranuronosyl)-6-O-sulfonato-D-glucopyranose; 2-Amino-2-deoxy-4-O-(4-deoxy-2-O-sulfo-alpha-L-threo-hex-4-enopyranuronosyl)-D-glucose 6-(hydrogen sulfate) trisodium salt; α-δUA-2S-[1->4]-GlcN-6S. Grades: 95%. CAS No. 136098-04-9. Molecular formula: C12H16NNa3O16S2. Mole weight: 563.35. | |
| Heparin disaccharide II-A disodium salt | It is a product of the action of heparinases II and III on heparin and heparin sulfate. Synonyms: Disodium 2-acetamido-2-deoxy-4-O-(4-deoxy-α-L-threo-hex-4-enopyranuronosyl)-6-O-sulfonato-D-glucopyranose; 2-(Acetylamino)-2-deoxy-4-O-(4-deoxy-alpha-L-threo-hex-4-enopyranuronosyl)-D-glucose 6-(hydrogen sulfate) disodium salt. Grades: ≥95%. CAS No. 136098-06-1. Molecular formula: C14H19NO14SNa2. Mole weight: 503.34. | |
| Heparin disaccharide II-H disodium salt | Heparin disaccharide II-H disodium salt is the major component from the action of heparinase II on de-N-sulfated heparin. Synonyms: Heparin unsaturated disaccharide II-H disodium salt; sodium (2R,3R,4S)-2-((2R,3S,4R,5R)-5-amino-4,6-dihydroxy-2-(sulfonatooxymethyl)tetrahydro-2H-pyran-3-yloxy)-3,4-dihydroxy-3,4-dihydro-2H-pyran-6-carboxylate; D-Glucopyranose, 2-amino-2-deoxy-4-O-(4-deoxy-α-L-threo-hex-4-enopyranuronosyl)-, 6-(hydrogen sulfate), sodium salt (1:2); Alpha-delta-ua-[1->4]-GlcN-6S sodium salt. Grades: ≥98%. CAS No. 136098-02-7. Molecular formula: C12H17NNa2O13S. Mole weight: 461.31. | |
| Heparin disaccharide III-A disodium salt | It is a minor product of the action of heparinase II on heparin. Synonyms: Disodium 2-acetamido-2-deoxy-4-O-(4-deoxy-2-O-sulfonato-α-L-threo-hex-4-enopyranuronosyl)-D-glucopyranose; 2-(Acetylamino)-2-deoxy-4-O-(4-deoxy-2-O-sulfo-alpha-L-threo-hex-4-enopyranuronosyl)-D-glucose disodium salt. Grades: ≥95%. CAS No. 136098-11-8. Molecular formula: C14H19NNa2O14S. Mole weight: 503.34. | |
| Heparin disaccharide III-H disodium salt | It is the major component from the action of heparinase II on de-N-sulfated heparin. Synonyms: alpha-DeltaUA-2S-[1->4]-GlcN; α-δua-2s-[1?4]-glcn; Disodium 2-amino-2-deoxy-4-O-(4-deoxy-2-O-sulfonato-α-L-threo-hex-4-enopyranuronosyl)-D-glucopyranose. Grades: ≥95%. CAS No. 136098-01-6. Molecular formula: C12H18NNaO13S. Mole weight: 439.33. | |
| Heparin disaccharide III-S trisodium salt | It is produced from heparin by digestion with heparinase I and II. Synonyms: Alpha-delta-ua-2s-[1->4]-glcns sodium salt; sodium (2R,3R,4S)-2-((2R,3S,4R,5R)-4,6-dihydroxy-2-(hydroxymethyl)-5-(sulfonatoamino)tetrahydro-2H-pyran-3-yloxy)-4-hydroxy-3-(sulfonatooxy)-3,4-dihydro-2H-pyran-6-carboxylate; Trisodium 2-deoxy-4-O-(4-deoxy-2-O-sulfonato-α-L-threo-hex-4-enopyranuronosyl)-2-(sulfonatoamino)-D-glucopyranose. Grades: ≥95%. CAS No. 136098-03-8. Molecular formula: C12H16NNa3O16S2. Mole weight: 563.35. | |
| Heparin disaccharide II-S trisodium salt | It is produced from heparinase II digestion of heparin and heparin sulphate. Synonyms: 2-Deoxy-4-O-(4-deoxy-α-L-threo-hex-4-enopyranuronosyl)-2-(sulfoamino)-D-glucose 6-(Hydrogen sulfate) Trisodium Salt; Alpha-delta-ua-[1->4]-glcns-6S sodium salt; Trisodium 2-deoxy-4-O-(4-deoxy-α-L-threo-hex-4-enopyranuronosyl)-6-O-sulfonato-2-(sulfonatoamino)-D-glucopyranose. CAS No. 136098-05-0. Molecular formula: C12H16NNa3O16S2. Mole weight: 563.35. | |
| Heparin disaccharide I-P trisodium salt | It is prepared from heparin unsaturated disaccharide I-H by n-propionylation. It is a homologue of disaccharide I-A with the inclusion of a methylene group in the amide acyl group. It does not occur in nature and was devised as an internal standard for HPLC, CZE and CE analysis of heparin/heparin sulfate. It is also ideally suited as an internal standard for HLPC/CZE analysis of chondroitin series, after digestion with chondroitinases. Synonyms: Heparin unsaturated disaccharide I-P trisodium salt; (α-δUA-2S-[1?4]-GlcNCOEt-6S); 2-Deoxy-3-O-[(1R)-4-deoxyhex-4-enopyranuronosyl]-2-(propionylamino)-D-glycero-hexopyranose trisodium salt. Grades: 95%. CAS No. 149368-05-8. Molecular formula: C15H20NNa3O17S2. Mole weight: 619.42. | |
| Heparin disaccharide IV-A, sodium salt | It is produced from heparin sulfate by digestion with heparinase III. Synonyms: ΔGlcAΔ(1-4)GlcNAc; sodium (2R,3R,4S)-2-((2R,3S,4R,5R)-5-acetamido-4,6-dihydroxy-2-(hydroxymethyl)tetrahydro-2H-pyran-3-yloxy)-3,4-dihydroxy-3,4-dihydro-2H-pyran-6-carboxylate; D-Glucopyranose, 2-(acetylamino)-2-deoxy-4-O-(4-deoxy-α-L-threo-hex-4-enopyranuronosyl)-, sodium salt (1:1); α-δ-UA-[1->4]-GLCNAC. Grades: ≥90%. CAS No. 136098-07-2. Molecular formula: C14H20NNaO11. Mole weight: 401.30. | |
| Heparin disaccharide IV-H | It is the product of digestion of heparin sulfate and heparin by various heparinases. Synonyms: alpha-delta-UA-[1->4]-GLCN; 2-Amino-2-deoxy-4-O-(4-deoxy-α-L-threo-hex-4-enopyranuronosyl)-D-glucose; D-Glucose, 2-amino-2-deoxy-4-O-(4-deoxy-α-L-threo-hex-4-enopyranuronosyl)-. Grades: 95%. CAS No. 123228-39-7. Molecular formula: C12H19NO10. Mole weight: 337.28. | |
| Heparin disaccharide IV-S disodium salt | It is produced from heparin sulfate by digestion with heparinase III. Synonyms: Heparin unsaturated disaccharide IV-S, disodium salt; sodium (2R,3R,4S)-2-((2R,3S,4R,5R)-4,6-dihydroxy-2-(hydroxymethyl)-5-(sulfonatoamino)tetrahydro-2H-pyran-3-yloxy)-3,4-dihydroxy-3,4-dihydro-2H-pyran-6-carboxylate; 2-Deoxy-4-O-(4-deoxy-alpha-L-threo-hex-4-enopyranuronosyl)-2-(sulfoamino)-D-glucose disodium salt. Grades: ≥90%. CAS No. 136098-08-3. Molecular formula: C12H17NNa2O13S. Mole weight: 461.31. | |
| Heparin sodium salt (Low in Ca) | Heparin sodium salt (Low in Ca) is a bioactive compound with potent anticoagulant properties that are essential in managing various blood clotting disorders, including deep vein thrombosis and pulmonary embolisms. Its unique mechanism of action involves the inhibition of blood clot formation, effectively reducing the risk of further complications. This specialized Heparin sodium salt formulation contains reduced levels of calcium, thus minimizing the potential incidence of the dreaded heparin-induced thrombocytopenia (HIT) syndrome. Complex yet highly effective, this anticoagulant therapy represents a crucial medical breakthrough in ensuring patient safety and well-being. | |
| Heparin sulfate oligosaccharide NAc | | |
| Heptadecyl 2-acetamido-2-deoxy-b-D-glucopyranoside | Heptadecyl 2-acetamido-2-deoxy-b-D-glucopyranoside, a biomedical marvel, unleashes its prowess in combatting a pantheon of afflictions. Acutely skilled in the art of inhibition, it zeroes in on fortes such as precise enzyme targeting, deftly impeding the advancement of select cancers and bacterial infections. This compound, adorned with therapeutic potential, engenders a cornucopia of auspicious outcomes within preclinical realms. Synonyms: Heptadecyl 2-acetamido-2-deoxy-beta-D-glucopyranoside; Heptadecyl 2-(acetylamino)-2-deoxy-beta-D-glucopyranoside; Heptadecyl-2-(acetylamino)-2-deoxy-I(2)-D-Glucopyranoside; N-[(2R,3R,4R,5S,6R)-2-heptadecoxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide; N-((2R,3R,4R,5S,6R)-2-(Heptadecyloxy)-4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-3-yl)acetamide; N-[(2R,3R,4R,5S,6R)-2-(HEPTADECYLOXY)-4,5-DIHYDROXY-6-(HYDROXYMETHYL)OXAN-3-YL]ACETAMIDE. CAS No. 262856-90-6. Molecular formula: C25H49NO6. Mole weight: 459.66. | |
| Heptadecyl 2-acetamido-3,4,6-tri-O-acetyl-2-deoxy-b-D-glucopyranoside | Heptadecyl 2-acetamido-3,4,6-tri-O-acetyl-2-deoxy-b-D-glucopyranoside, a crucial compound in the biomedical field, exhibits significant importance. It finds extensive applications in the realm of antiviral drug development as well as the investigation of infectious diseases. Synonyms: (2R,3S,4R,5R,6R)-5-Acetamido-2-(acetoxymethyl)-6-(heptadecyloxy)tetrahydro-2H-pyran-3,4-diyl diacetate; [(2R,3S,4R,5R,6R)-5-acetamido-3,4-diacetyloxy-6-heptadecoxyoxan-2-yl]methyl acetate; Heptadecyl 2-acetamido-3,4,6-tri-O-acetyl-2-deoxy-beta-D-glucopyranoside;Heptadecyl-2-(acetylamino)-2-deoxy-3,4,6-triacetate-I(2)-D-Glucopyranoside; (2R,3S,4R,5R,6R)-5-Acetamido-2-(acetoxymethyl)-6-(heptadecyloxy)tetrahydro-2H-pyran-3,4-diyldiacetate; [(2R,3S,4R,5R,6R)-3,4-BIS(ACETYLOXY)-5-ACETAMIDO-6-(HEPTADECYLOXY)OXAN-2-YL]METHYL ACETATE. CAS No. 262856-89-3. Molecular formula: C31H55NO9. Mole weight: 585.77. | |
| Heptakis(2,3,6-tri-O-benzoyl)cyclomaltoheptaose | Heptakis(2,3,6-tri-O-benzoyl)cyclomaltoheptaose, a derivative of cyclodextrin, presents an exceptional ability to encapsulate hydrophobic molecules, endorsing solubility and bioavailability of drugs. Its innovative therapeutic applications for cancer and drug-resistant fungal infections have been extensively researched, substantiating its potential as a vanguard drug delivery system. Synonyms: Heptakis-(2,3,6-tri-O-benzoyl)-b-cyclodextrin. CAS No. 23666-43-5. Molecular formula: C189H154O56. Mole weight: 3321.21. | |
| Heptakis(2,3,6-tri-O-ethyl)cyclomaltoheptaose | Heptakis(2,3,6-tri-O-ethyl)cyclomaltoheptaose is a biomedicine product utilized in the treatment of various drug delivery systems and targeted therapies. Its applications include encapsulating and delivering drugs specifically to treat liver diseases, cancer, and other chronic conditions. With its unique structure, this product enhances drug solubility, stability, and bioavailability, fostering effective treatment outcomes. Synonyms: Heptakis-(2,3,6-tri-O-ethyl)-b-cyclodextrin. CAS No. 111689-01-1. Molecular formula: C84H154O35. Mole weight: 1724.10. | |
| Heptakis(2,3,6-tri-O-methyl)cyclomaltoheptaose | Heptakis(2,3,6-tri-O-methyl)cyclomaltoheptaose is a derivative of β-cyclodextrin, which is a solubilizing and stabilizing agent. Synonyms: Trimethyl-b-cyclodextrin; Heneicosa-O-methyl-b-cyclodextrin; 2,3,6-Tri-O-methyl-β-cyclodextrin; 2,3,6-Trimethyl-β-cyclodextrin; Cydex-β; Hepta-(2,3,6-tri-oxy-methyl)-β-cyclodextrin; Heptakis(2,3,6-tri-O-methyl)-β-cyclodextrin; Hydrodex β-PM; Me21-β-CD; Per-O-methyl-β-cyclodextrin; Permethyl-β-cyclodextrin; Tri-O-methyl-β-cyclodextrin; β-Cyclodextrin permethyl ether. Grades: ≥98%. CAS No. 55216-11-0. Molecular formula: C63H112O35. Mole weight: 1429.54. | |
| Heptakis (2, 3-di-O-acetyl-6-O-tert-butyldimethylsilyl) cyclomaltoheptaose | Heptakis (2, 3-di-O-acetyl-6-O-tert-butyldimethylsilyl) cyclomaltoheptaose, a highly significant compound extensively utilized in the biomedical sector, assumes a pivotal role in diverse therapeutic applications. With its remarkable capacity to effectively combat numerous afflictions, this product stands out as an indispensable entity within the realm of modern biomedical research and development. Beneath its intricately designed structure lies a potent agent capable of precisely targeting specific medications or facilitating the development of innovative drug delivery systems. Synonyms: Silyl(6-O-tert-butyldimethyl)-2,3-di-acetyl)-b-cyclodextrin; Heptakis(6-O-tert-butyldimethylsilyl)-b-cyclodextrin tetradecaacetate. CAS No. 123172-94-1. Molecular formula: C112H196O49Si7. Mole weight: 2523.32. | |
| Heptakis(2,3-di-O-acetyl-6-sulfo)-beta-cyclodextrin sodium salt | Heptakis(2,3-di-O-acetyl-6-sulfo)-beta-cyclodextrin sodium salt is a remarkable biomedical compound, acting as an efficacious drug carrier. It exhibits profound capabilities in augmenting the solubility, stability and bioavailability of pharmaceutical compounds. CAS No. 196398-66-0. Molecular formula: C70H91O70S7Na7. Mole weight: 2437.8. | |
| Heptakis(2,3-di-O-acetyl)-β-cyclodextrin | Heptakis(2,3-di-O-acetyl)-β-cyclodextrin is an intermediate formed in the synthesis of Heptakis(6-O-sulfo)-β-cyclodextrin Heptasodium Salt, a β-Cyclodextrin derivative that inhibits anthrax lethal toxin. Chiral selector for capillary electrophorese, CE. Synonyms: 2, 4, 7, 9, 12, 14, 17, 19, 22, 24, 27, 29, 32, 34-Tetradecaoxaoctacyclo[31.2.2.23, 6.28, 11.213, 16.218, 21.223, 26.228, 31]nonatetracontane β-Cyclodextrin Deriv.; Per-2,3-acetyl-β-cyclodextrin; 2A, 2B, 2C, 2D, 2E, 2F, 2G, 3A, 3B, 3C, 3D, 3E, 3F, 3G-Tetradecaacetate-β-cyclodextrin. CAS No. 116389-66-3. Molecular formula: C70H98O49. Mole weight: 1723.5. | |
| Heptakis(2,3-di-O-ethyl-6-O-tert-butyldimethylsilyl)-β-cyclodextrin | Heptakis(2,3-di-O-ethyl-6-O-tert-butyldimethylsilyl)-β-cyclodextrin is a β-Cyclodextrin derivative. β-Cyclodextrin is a cyclic oligosaccharide produced from starch via enzymatic conversion. β-Cyclodextrin is commonly used to produce HPLC columns allowing chiral enantiomers separation. Synonyms: 6A, 6B, 6C, 6D, 6E, 6F, 6G-Heptakis-O-[(1, 1-dimethylethyl)dimethylsilyl]-2A, 2B, 2C, 2D, 2E, 2F, 2G, 3A, 3B, 3C, 3D, 3E, 3F, 3G-tetradeca-O-ethyl-β-cyclodextrin. CAS No. 183498-07-9. Molecular formula: C112H224O35Si7. Mole weight: 2327.55. | |
| Heptakis(2,3-di-O-methyl-6-deoxy-6-amino)-beta-cyclodextrin heptahydrochloride | Heptakis(2,3-di-O-methyl-6-deoxy-6-amino)-beta-cyclodextrin heptahydrochloride is a pivotal compound employed sector with ability to study drug solubility and stability. It contributes significantly to enhancing their bioavailability. Molecular formula: C56H112O28N7Cl7. Mole weight: 1579.7. | |
| Heptakis(2,3-di-O-methyl)-hexakis(6-O-methyl)-6-monodeoxy-6-monoamino-beta-cyclodextrin hydrochloride | Heptakis(2,3-di-O-methyl)-hexakis(6-O-methyl)-6-monodeoxy-6-monoamino-beta-cyclodextrin hydrochloride is a novel drug delivery system widely used in the biomedical industry. This product plays a crucial role in enhancing the solubility and stability of various drugs, including those used to treat cancer, infectious diseases, and neurodegenerative disorders. Its unique structure facilitates efficient drug encapsulation, improving therapeutic efficacy while reducing side effects. Molecular formula: C62H112O34NCl. Mole weight: 1451.0. | |
| Heptakis(2,3-di-O-metyhl-6-deoxy-6-azido)-beta-cyclodextrin | Heptakis(2,3-di-O-metyhl-6-deoxy-6-azido)-beta-cyclodextrin is a specialized drug delivery system used in biomedicine. It encapsulates and transports drugs to specific cells or tissues, aiding in the treatment of various diseases. Its unique structure allows for controlled release, enhancing drug efficacy and reducing side effects. Molecular formula: C56H91O28N21. Mole weight: 1506.4. | |
| Heptakis(6-amino-6-deoxy)-beta-cyclodextrin | Heptakis(6-amino-6-deoxy)-beta-cyclodextrin is a derivate of β-Cyclodextrin. β-Cyclodextrin is commonly used to produce HPLC columns allowing chiral enantiomers separation. Synonyms: Per-6-amino-beta-cyclodextrin. CAS No. 30754-24-6. Molecular formula: C42H77N7O28. Mole weight: 1128.09. | |
| Heptakis(6-deoxy-6-amino)-beta-cyclodextrin heptahydrochloride | Heptakis(6-deoxy-6-amino)-beta-cyclodextrin heptahydrochloride is an advanced biopharmaceutical, acting as an adept drug carrier. It excels in encapsulation and augmentation of molecular solubility. Remarkably, its distinctive configuration facilitates precise drug delivery. CAS No. 65024-90-0. Molecular formula: C42H84O28N7Cl7. Mole weight: 1383.3. | |
| Heptakis(6-O-sulfo)-β-cyclodextrin Tetradecaacetate Heptapyridium Salt | A β-Cyclodextrin derivative. Uses: A β-cyclodextrin derivative. Synonyms: 2A, 2B, 2C, 2D, 2E, 2F, 2G, 3A, 3B, 3C, 3D, 3E, 3F, 3G-Tetradecaacetate 6A,6B,6C,6D,6E,6F,6G-Heptakis(hydrogen sulfate) β-Cyclodextrin Pyridium Salt; 6-O-Sulfo-β-cyclodextrin Tetradecaacetate Pyridium Salt. CAS No. 196398-65-9. Molecular formula: C105H133Na7O70S7. Mole weight: 2837.66. | |
| Heptakis-(6-O-tert-butyldimethylsilyl)-β-cyclodextrin | A β-Cyclodextrin derivative. Synonyms: Heptakis-6-(dimethyl-tert-butylsilyl)-6-deoxy-β-cyclodextrin; Tetradecakis[α-methyl-4-(2-methylpropyl)benzeneacetate] 6A,6B,6C,6D,6E,6F,6G-Heptakis-O-[(1,1-dimethylethyl)dimethylsilyl]-β-cyclodextrin (14:1). Molecular formula: C84H168O35Si7. Mole weight: 1934.81. | |
| Hepta-O-acetyl-b-Lactosyl-N-Fmoc-L-serine | Hepta-O-acetyl-b-Lactosyl-N-Fmoc-L-serine is an indispensable biomedical compound with inherent potentiality in studying multifarious diseases, particularly malignant neoplasms and intricate disorders. Synonyms: (2S)-3-[(2R,3R,4S,5R,6R)-3,4-Diacetyloxy-6-(acetyloxymethyl)-5-[(2S,3R,4S,5S,6R)-3,4,5-triacetyloxy-6-(acetyloxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-2-(9H-fluoren-9-ylmethoxycarbonylamino)propanoic acid; N-(9-Fluorenylmethoxycarbonyl)-O-(2,3,6,2',3',4',6'-hepta-O-acetyl-beta-D-lactosyl)-L-serine; Fmoc-L-Ser(beta-D-Lac(Ac)7)-OH; MFCD03452817; N-(9-Fluorenylmethoxycarbonyl)-O-(2,3,6,2',3',4',6'-hepta-O-acetyl-b-D-lactosyl)-L-serine; N-(((9H-Fluoren-9-yl)methoxy)carbonyl)-O-((2R,3R,4S,5R,6R)-3,4-diacetoxy-6-(acetoxymethyl)-5-(((2S,3R,4S,5S,6R)-3,4,5-triacetoxy-6-(acetoxymethyl)tetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)-L-serine. CAS No. 169275-84-7. Molecular formula: C44H51NO22. Mole weight: 945.88. | |
| Hepta-O-acetyl-b-Lactosyl-N-Fmoc-L-threonine | Hepta-O-acetyl-b-Lactosyl-N-Fmoc-L-threonine is an extensively studied and innovative compound, finding applications in enhancing drug delivery systems. This product exhibits its remarkable utility in studying diverse ailments such as cancer and inflammatory disorders. Synonyms: Fmoc-Thr(beta-D-Lac(Ac)7)-OH; 657395-98-7; 3-[3,4-diacetyloxy-6-(acetyloxymethyl)-5-[3,4,5-triacetyloxy-6-(acetyloxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-2-(9H-fluoren-9-ylmethoxycarbonylamino)butanoic acid; L-Threonine,N-[(9H-fluoren-9-ylmethoxy)carbonyl]-O-[2,3,6-tri-O-acetyl-4-O-(2,3,4,6-tetra-O-acetyl-b-D-galactopyranosyl)-b-D-glucopyranosyl]-; AKOS037643235; AS-11157. CAS No. 657395-98-7. Molecular formula: C45H53NO22. Mole weight: 959.90. | |
| Hepta-O-acetylrutinose | Hepta-O-acetylrutinose is a highly versatile and multifunctional biomedical compound with anti-inflammatory and antitumor properties. Synonyms: Rutinose peracetate; 6-O-(2,3,4-tri-O-acetyl-6-deoxy-a-L-mannopyranosyl)-1,2,3,4-tetra-O-acetyl-D-glucopyranose. CAS No. 29202-64-0. Molecular formula: C26H36O17. Mole weight: 620.57. | |
| Heptatrimethylsilyl D-Lactose-6-ol | Heptatrimethylsilyl D-Lactose-6-ol is an intermediate in synthesizing Cetirizine 6,6'-O-Lactose Ester Dihydrochloride(6,6'-Mixture), a lactose adduct of Cetirizine. Synonyms: ( (2R, 3S, 4S, 5R, 6S) -3, 4, 5-Tris ( (trimethylsilyl) oxy) -6- ( ( (2R, 3R, 4S, 5R, 6S) -4, 5, 6-tris ( (trimethylsilyl) oxy) -2- ( ( (trimethylsilyl) oxy) methyl) tetrahydro-2H-pyran-3-yl) oxy) tetrahydro-2H-pyran-2-yl) methanol. Molecular formula: C33H78O11Si7. Mole weight: 847.56. | |
| Heptatrimethylsilyl D-Lactose-6'-ol | Heptatrimethylsilyl D-Lactose-6'-ol is an intermediate in synthesizing Cetirizine 6,6'-O-Lactose Ester Dihydrochloride(6,6'-Mixture), a lactose adduct of Cetirizine. Synonyms: ( (2R, 3R, 4S, 5R, 6S) -4, 5, 6-tris ( (trimethylsilyl) oxy) -3- ( ( (2S, 3R, 4S, 5S, 6R) -3, 4, 5-tris ( (trimethylsilyl) oxy) -6- ( ( (trimethylsilyl) oxy) methyl) tetrahydro-2H-pyran-2-yl) oxy) tetrahydro-2H-pyran-2-yl) methanol. Molecular formula: C33H78O11Si7. Mole weight: 847.56. | |
| Heptatrimethylsilyl D-Lactose Acetate | Heptatrimethylsilyl D-Lactose Acetate is an intermediate in synthesizing Cetirizine 6,6'-O-Lactose Ester Dihydrochloride(6,6'-Mixture), a lactose adduct of Cetirizine. Synonyms: (3R, 4S, 5R, 6R) -3, 4-Bis ( (trimethylsilyl) oxy) -6- ( ( (trimethylsilyl) oxy) methyl) -5- ( ( (2S, 3R, 4S, 5S, 6R) -3, 4, 5-tris ( (trimethylsilyl) oxy) -6- ( ( (trimethylsilyl) oxy) methyl) tetrahydro-2H-pyran-2-yl) oxy) tetrahydro-2H-pyran-2-yl Acetate. Molecular formula: C35H80O12Si7. Mole weight: 889.6. | |
| Heptyl 2-acetamido-3,4,6-tri-O-acetyl-2-deoxy-b-D-glucopyranoside | Heptyl 2-acetamido-3,4,6-tri-O-acetyl-2-deoxy-b-D-glucopyranoside is an extensively studied biomedical compound, aiding in drug discovery endeavors targeting afflictions such as rheumatoid arthritand neurodegenerative disorders. CAS No. 115431-24-8. Molecular formula: C21H35NO9. Mole weight: 445.5. | |
| Heptyl b-D-glucopyranoside | Heptyl b-D-glucopyranoside, a frequently utilized compound in the biomedical sector, presents substantial promise as a drug carrier, particularly for the treatment of ailments such as cancer. Its capacity to augment drug effectiveness and diminish toxicity renders it a highly favorable prospect for targeted drug delivery systems. Given its manifold properties and advantages, it assumes a paramount role in diverse biomedical applications. Synonyms: Heptyl beta-D-glucopyranoside; HEPTYL-BETA-D-GLUCOPYRANOSIDE; heptyl glucoside; (2R,3R,4S,5S,6R)-2-(Heptyloxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol; n-Heptyl beta-D-glucopyranoside; BU2OC48XBR; n-Heptyl beta-D-glucoside; 1-Heptyl beta-D-glucoside; (2R,3R,4S,5S,6R)-2-heptoxy-6-(hydroxymethyl)oxane-3,4,5-triol; MFCD00063299; Heptyl b-D-glucopyranoside; 128052-80-2; B7G; Heptyl-b-D-glucopyranoside.beta.-D-Glucopyranoside, heptyl; UNII-BU2OC48XBR; N-HEPTYL-BETA-D-GLC; n-Heptyl-ss-D-glucopyranosid; SCHEMBL333088; beta-D-Glucopyranoside, heptyl; n-Heptyl |A-D-glucopyranoside1111. CAS No. 78617-12-6. Molecular formula: C13H26O6. Mole weight: 278.34. | |
| Heptyl b-D-thioglucopyranoside | Heptyl b-D-thioglucopyranoside, a biochemical surfactant and detergent utilized in the biomedicine industry, is a paramount instrument for the investigation of human ailments. Through its application in the purification and analysis of cell membrane proteins, this compound sustains pivotal discoveries pertaining to neurodegenerative conditions like Alzheimer's, Parkinson's, and Huntington's. CAS No. 85618-20-8. Molecular formula: C13H26O5S. Mole weight: 294.41. | |
| Hesperetin 3'-O-β-D-glucuronide | Hesperetin 3'-O-β-D-glucuronide is a compound utilized in the research of various diseases. With its ability to modulate intracellular signaling pathways, this compound shows potential in studying cancer, inflammation and cardiovascular disorders. Additionally, Hesperetin 3'-O-β-D-glucuronide exhibits antioxidant properties, making it a valuable tool in studying oxidative stress-related conditions. Synonyms: β-D-Glucopyranosiduronic acid,5-[(2S)-3,4-dihydro-5,7-dihydroxy-4-oxo-2H-1-benzopyran-2-yl]-2-methoxyphenyl. CAS No. 150985-66-3. Molecular formula: C22H22O12. Mole weight: 478.40. | |
| Hesperetin 7,3'-O-b-D-glucuronide | Hesperetin 7,3'-O-b-D-glucuronide is a biosynthetic derivative, extracted meticulously from the depths of hesperidin. It is an illustrious flavonoid. With its immaculate amalgamation of potent antioxidant and anti-inflammatory attributes, this prodigious compound aidis in studying menacing cardiovascular maladies, pernicious cancers and enigmatic neurodegenerative malfunctions. Grades: ≥ 95%. Molecular formula: C28H30O18. Mole weight: 654.53. | |
| Hesperetin-d3 3'-O-β-D-glucuronide | | |
| Hexacarboxybenzyl Neomycin C | Hexa-carboxybenzyl Neomycin C is an intermediate in synthesizing Neomycin C Hexaacetate, which is an aminoglycoside antibiotic found in many topical medications. Neomycin has been used as a preventive measure for hepatic encephalopathy and hypercholesterolemia. Synonyms: O-2,6-Dideoxy-2,6-bis[[(phenylmethoxy)carbonyl]amino]-α-D-glucopyranosyl-(1?3)-O-β-D-ribofuranosyl-(1?5)-O-[2,6-dideoxy-2,6-bis[[(phenylmethoxy)carbonyl]amino]-α-D-glucopyranosyl-(1?4)]-2-deoxy-N1,N3-bis[(phenylmethoxy)carbonyl]-D-streptamine. CAS No. 1216950-86-5. Molecular formula: C71H82N6O25. Mole weight: 1419.44. | |
| Hexacarboxybenzyl Neomycin C Hepta-acetate | Hexacarboxybenzyl Neomycin C Hepta-acetate is an intermediate in synthesizing Neomycin C Hexaacetate, which is an aminoglycoside antibiotic found in many topical medications. Neomycin has been used as a preventive measure for hepatic encephalopathy and hypercholesterolemia. Synonyms: (2R, 3R, 4R, 5R, 6R) -6- ( ( (1R, 2S, 3S, 4R, 6S) -3-Acetoxy-2- ( ( (2S, 3R, 4R, 5R) -3-acetoxy-5- (acetoxymethyl) -4- ( ( (2R, 3R, 4R, 5R, 6R) -4, 5-diacetoxy-3- ( ( (benzyloxy) carbonyl) amino) -6- ( ( ( (benzyloxy) carbonyl) amino) methyl) tetrahydro-2H-pyran-2-yl) oxy) tetrahydrofuran-2-yl) oxy) -4, 6-bis ( ( (benzyloxy) carbonyl) amino) cyclohexyl) oxy) -5- ( ( (benzyloxy) carbonyl) amino) -2- ( ( ( (benzyloxy) carbonyl) amino) methyl) tetrahydro-2H-pyran-3, 4-diyl Diacetate. Molecular formula: C85H96N6O32. Mole weight: 1713.69. | |
| Hexadecasaccharide dp16 | Hexadecasaccharide dp16 is an innovative biomedical product assuming a pivotal role in the formulation of potent pharmaceuticals. It aids in studying a wide spectrum of maladies, spanning from aggressive infections to debilitating inflammations and even life-threatening thrombotic events. Synonyms: Heparin derived dp16 saccharide ammonium salt. Grades: ≥75%. Molecular formula: C96H120N8O152S24(NH4)32. Mole weight: 5164.72. | |
| Hexadecyl 2-acetamido-2-deoxy-b-D-glucopyranoside | Hexadecyl 2-acetamido-2-deoxy-b-D-glucopyranoside, an esteemed and influential biomedical compound, exhibits prodigious potential in the realm of combating cancer. Aptly derived from glucose, this remarkable entity assumes the role of an efficacious inhibitor, hampering the unwarranted expansion of malignant tumors. Its exceptional attributes lie in its adeptness at meticulously targeting and curbing the proliferation of neoplastic cells, thus holding promise for diversified cancer treatments. Synonyms: Hexadecyl 2-acetamido-2-deoxy-b-D-glucopyranoside; N-[(2R,3R,4R,5S,6R)-2-hexadecoxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide; W-200884; Hexadecyl-2-(acetylamino)-2-deoxy-I(2)-D-Glucopyranoside; N-((2R,3R,4R,5S,6R)-2-(Hexadecyloxy)-4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-3-yl)acetamide; N-[(2R,3R,4R,5S,6R)-2-(HEXADECYLOXY)-4,5-DIHYDROXY-6-(HYDROXYMETHYL)OXAN-3-YL]ACETAMIDE. CAS No. 115414-49-8. Molecular formula: C24H47NO6. Mole weight: 445.63. | |
| Hexadecyl 2-acetamido-3,4,6-tri-O-acetyl-2-deoxy-b-D-glucopyranoside | Hexadecyl 2-acetamido-3,4,6-tri-O-acetyl-2-deoxy-b-D-glucopyranoside, affectionately known as HDATODG, emerges as an indispensable biomedical marvel, bestowed with extraordinary abilities to combat a plethora of ailments. Its efficacy reigns supreme in tackling unruly bacterial invasions, instigating a revolution in the treatment landscape for infectious maladies. This versatile compound, revered for its unmatched prowess, also lends a helping hand in mitigating afflictions afflicting the integumentary system and unraveling the enigmatic complexities of inflammatory disorders. Synonyms: [(2R,3S,4R,5R,6R)-5-Acetamido-3,4-diacetyloxy-6-hexadecoxyoxan-2-yl]methyl acetate; (2R,3S,4R,5R,6R)-5-Acetamido-2-(acetoxymethyl)-6-(hexadecyloxy)tetrahydro-2H-pyran-3,4-diyl diacetate; Hexadecyl-2-(acetylamino)-2-deoxy-3,4,6-triacetateI(2)-D-Glucopyranoside; [(2R,3S,4R,5R,6R)-3,4-BIS(ACETYLOXY)-5-ACETAMIDO-6-(HEXADECYLOXY)OXAN-2-YL]METHYL ACETATE. CAS No. 115414-47-6. Molecular formula: C30H53NO9. Mole weight: 571.74. | |
| Hexadecyl b-D-glucopyranoside | Hexadecyl b-D-glucopyranoside is an extensively utilized synthetic compound in the biomedical industry, exhibiting notable characteristics that make it exceptional in drug delivery systems and as a solubilizing compound for hydrophobic drugs. Acting as a surfactant and detergent in diverse research applications, this compound contributes significantly to the researchs for a myriad of diseases. Synonyms: Hexadecyl glucoside. Molecular formula: C22H44O6. Mole weight: 404.58. | |
Our database is helping our users find suppliers everyday.
